Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach

NCT05420727 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Ga-68-PSMA-11 PET/CT
DRUG: Lu-177-ITG-PSMA-1

Sponsor

John O. Prior